Cheryl Willman, MD in Albuquerque, TX - Pathology

Cheryl Willman, MD is a Pathology - Clinical Pathology/laboratory Medicine physician based in Albuquerque, Texas. Cheryl Willman is licensed to practice in Texas (license number 85-126) and her current practice location is 2325 Camino De Salud Ne, Unm Cancer Research - Treatment Center, Albuquerque, Texas. She can be reached at her office (for appointments etc.) via phone at (505) 272-5622.

NPI number for Cheryl Willman is 1124035175 and her current mailing address is 2325 Camino De Salud Ne, Msc08 4630, Albuquerque, Texas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1124035175.

Contact Information

	Cheryl Willman, MD
	2325 Camino De Salud Ne, Unm Cancer Research - Treatment Center, Albuquerque, TX 87131
	(505) 272-5622
	Not Available

Physician's Profile

Full Name	Cheryl Willman
Gender	Female
Speciality	Pathology - Clinical Pathology/laboratory Medicine
Location	2325 Camino De Salud Ne, Albuquerque, Texas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1124035175
Provider Enumeration Date: 08/02/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Cheryl Willman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1124035175	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0105X	Pathology - Clinical Pathology/laboratory Medicine	85-126 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Cheryl Willman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Cheryl Willman, MD 2325 Camino De Salud Ne, Msc08 4630, Albuquerque, TX 87131 Ph: (505) 272-5622	Cheryl Willman, MD 2325 Camino De Salud Ne, Unm Cancer Research - Treatment Center, Albuquerque, TX 87131 Ph: (505) 272-5622

News Archive

East Liverpool City Hospital, Foundation Radiology Group enter imaging services agreement

Foundation Radiology Group, the premier provider of diagnostic imaging professional services for community hospitals, is pleased to announce its exclusive imaging services agreement with East Liverpool City Hospital located in East Liverpool, Ohio.

NIH awards $8 million to The Medical College of Wisconsin for heart research

The Medical College of Wisconsin has been awarded a five-year, $8 million, multi-investigator Program Project Grant (PPG) from the National Institutes of Health to understand how human pluripotent stem cells, defined as cells which if left to their own designs can develop into any of the more than 200 cell types in the human body, can be channeled to exclusively become heart muscle cells.

Topical cream shows signs of clinical efficacy in patients with basal cell carcinoma

Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma.

Computer search algorithms identify FDA-approved drugs that could be the basis for new medicines

A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines - if emerging viruses such as the H5N1(avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies - according to a presentation at the American Society for Cell Biology (ASCB) 49th Annual Meeting, Dec. 5-9, 2009 in San Diego.

Gastrointestinal symptoms in children could be a red flag for future mental health problems

A Columbia University study has found that adversity early in life is associated with increased gastrointestinal symptoms in children that may have an impact on the brain and behavior as they grow to maturity.

Cheryl Willman, MD - Pathology in Albuquerque, TX